Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pros

18.63
+0.38002.08%
Volume:555.18K
Turnover:10.35M
Market Cap:891.49M
PE:-68.69
High:18.99
Open:18.34
Low:18.34
Close:18.25
Loading ...

PROS Appoints Growth Veteran Katie May to Board of Directors

Business Wire
·
18 Mar

Prophecy International Holdings Limited's (ASX:PRO) Price Is Right But Growth Is Lacking

Simply Wall St.
·
18 Mar

Three XPO Leaders Named 2025 “Pros to Know” by Supply & Demand Chain Executive Magazine

GlobeNewswire
·
17 Mar

Garmin G3000 PRIME unveiled as integrated flight deck for the new Pilatus PC-12 PRO aircraft

PR Newswire
·
17 Mar

PRO Real Estate Investment Trust: Buy Rating Affirmed on Growth Potential and Valuation Discount

TIPRANKS
·
13 Mar

DuPont de Nemours (NYSE:DD) Unveils WAVE PRO Tool Enhancing Water Treatment Efficiency and Collaboration

Simply Wall St.
·
12 Mar

IFF Extends Enviva® PRO Probiotic Range to Improve Swine Welfare

PR Newswire
·
11 Mar

POLARIS SWEEPS 2025 MINT 400 AS HEGER CONTINUES HIS DESERT DOMINANCE WITH A COMMANDING OVERALL WIN IN RZR PRO R FACTORY

PR Newswire
·
11 Mar

DuPont Water Solutions Launches WAVE PRO for Ultrafiltration Modeling

PR Newswire
·
10 Mar

LOWE'S STYLE STUDIO™ FOR APPLE VISION PRO EXPANDS TO LOWE'S STORES IN AUSTIN, TEXAS

PR Newswire
·
10 Mar

PROS Holdings, Inc. (PRO) to Launch AI Agents for Revenue Optimization at Outperform 2025

Insider Monkey
·
08 Mar

PROS Set to Unveil New Agentic AI Offerings at Outperform 2025

Business Wire
·
06 Mar

Tax Rules and IRS Staffing Are in Flux. Here's What the Pros Say to Do Now. -- Barrons.com

Dow Jones
·
06 Mar

THE HOME DEPOT NAMES MICHAEL ROWE EVP OF PRO; STEPHANIE SMITH TO BECOME EVP OF HUMAN RESOURCES

PR Newswire
·
05 Mar

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor

PR Newswire
·
28 Feb

Neurocrine Biosciences Reports Patient-Reported Outcome Data from KINECT-PRO™ Study for INGREZZA® (valbenazine) Capsules in Tardive Dyskinesia: Significant and Clinically Meaningful Improvements in Functionality and Quality of Life Measures

PR Newswire
·
28 Feb

Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

GlobeNewswire
·
27 Feb

U.S. Department of Defense’s Defense Innovation Unit Adds Mobilicom’s SkyHopper PRO Micro to Blue UAS Framework

GlobeNewswire
·
25 Feb

Alcon a launches OTC eye drop SYSTANE PRO preservative-free PF

TIPRANKS
·
24 Feb

Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet

Business Wire
·
24 Feb